View in EDS

Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.

Saved in:
Bibliographic Details
Title: Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.
Authors: Cosgrove, Casey M.1, Cohn, David E.1, Hampel, Heather2, Frankel, Wendy L.3, Jones, Dan3, McElroy, Joseph P.4, Suarez, Adrian A.3, Zhao, Weiqiang3, Chen, Wei3, Salani, Ritu1, Copeland, Larry J.1, O'Malley, David M.1, Fowler, Jeffrey M.1, Yilmaz, Ahmet3, Chassen, Alexis S.1, Pearlman, Rachel2, Goodfellow, Paul J.1 Paul.Goodfellow@osumc.edu, Backes, Floor J.1
Source: Gynecologic Oncology. Sep2017, Vol. 146 Issue 3, p588-595. 8p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2017.07.003